Cipla

Cipla recalls over 1.8k boxes of generic drug in US due to broken tablets

As per the USFDA, New Jersey-based Cipla USA, Inc is recalling the affected lot due to "complaints received of crushed and broken tablets".

22 hours ago

Cipla recalls over 1.8k boxes of generic drug in US due to broken tablets

22 hours ago

Cipla gets 8 observations from USFDA for Bengaluru facility

The US Food and Drugs Administration (USFDA) conducted an inspection at the company's manufacturing facility in Virgonagar, Bengaluru from November 7- 13.

13 November 2024, 20:00 IST

Cipla gets 8 observations from USFDA for Bengaluru facility

13 November 2024, 20:00 IST

Cipla expects to commence supplies to US from China plant later this year

MD and global CEO Umag Vohra informed shareholders that the company is looking to target new therapeutic areas like obesity-related diseases, and liver conditions while investing heavily in tech-based solutions for various ailments.

28 July 2024, 07:00 IST

Cipla expects to commence supplies to US from China plant later this year

28 July 2024, 07:00 IST

Amid spices row, Cipla, Glenmark now recall India-made drugs from US market

As per USFDA, a class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

05 May 2024, 10:45 IST

Amid spices row, Cipla, Glenmark now recall India-made drugs from US market

05 May 2024, 10:45 IST

Cipla to acquire Ivia Beaute's cosmetics, personal care distribution and marketing business for Rs 130 crore

The acquisition will include Ivia Beaute's brands namely Astaberry, Ikin and Bhimsaini on a worldwide basis, the company said.

16 April 2024, 07:10 IST

Cipla to acquire Ivia Beaute's cosmetics, personal care distribution and marketing business for Rs 130 crore

16 April 2024, 07:10 IST

Cipla eyes acquisitions, inorganic partnerships in US market

Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments in the domestic market.

04 February 2024, 05:38 IST

Cipla eyes acquisitions, inorganic partnerships in US market

04 February 2024, 05:38 IST

Cipla stocks jump over 7% after earnings announcement

The company's shares climbed 7.35% to close at Rs 1,409.05 apiece on the Bombay Stock Exchange.

23 January 2024, 13:45 IST

Cipla stocks jump over 7% after earnings announcement

23 January 2024, 13:45 IST

Cipla shares rally nearly 8% after Q3 earnings results

In the mid-trading session on Tuesday, the 30-share BSE Sensex declined 708.90 points or 0.99 per cent lower trading at 70,714.75, while NSE Nifty slumped 1.05 per cent to trade at 21,344.40 points.

23 January 2024, 10:16 IST

Cipla shares rally nearly 8% after Q3 earnings results

23 January 2024, 10:16 IST

Cipla unit recalls one lot of medication in US due to seal integrity issue

The medication is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients two years of age and older who have responded adequately to several alternative treatments.

10 December 2023, 12:49 IST

Cipla unit recalls one lot of medication in US due to seal integrity issue

10 December 2023, 12:49 IST

Cipla profit rises 45% to Rs 1,156 crore, sales up 14.4% to Rs 6,590 crore in Q2

Consolidated total revenue from the sale of products in the quarter under review stood at Rs 6,589.22 crore, up 14.41 per cent, as against Rs 5,759.28 crore in the year-ago period.

27 October 2023, 12:21 IST

Cipla profit rises 45% to Rs 1,156 crore, sales up 14.4% to Rs 6,590 crore in Q2

27 October 2023, 12:21 IST